Results 121 to 130 of about 63,717 (177)

Real-world characteristics of systemic mastocytosis in Romania: insights from a reference-center-based descriptive study. [PDF]

open access: yesJ Med Life
Soare D   +8 more
europepmc   +1 more source

Systemic Mastocytosis

Hematology/Oncology Clinics of North America, 2010
An unusual disease, mastocytosis challenges the pathologist with a variety of morphologic appearances and heterogeneous clinical presentations ranging from skin manifestations (pruritus, urticaria, dermatographism) to systemic signs and symptoms indicative of mast cell mediator release, including flushing, hypotension, headache, and anaphylaxis among ...
Tracy I, George, Hans-Peter, Horny
openaire   +5 more sources

Avapritinib for Systemic Mastocytosis

Expert Review of Hematology, 2021
Systemic mastocytosis (SM) is a rare myeloid neoplasm driven in ≈95% of cases by activating KIT mutations, usually D816V. SM can be indolent (ISM), smoldering (SSM) and advanced (AdvSM), the latter characterized by organ damage resulting from infiltrating neoplastic mast cells.
Prithviraj Bose, Srdan Verstovsek
openaire   +2 more sources

Systemic mastocytosis

Blood, 2013
Clinical History: A 77–year-old woman was seen by her general practitioner because of a changed defecation pattern. On a CT colonography, which was otherwise normal, bone abnormalities were present. The patient had no previous history of malignancy.
Bouvier, Sylvie, Arnaud, Anne
  +6 more sources

Systemic Mastocytosis and the Mastocytosis Syndrome

Journal of Cutaneous Pathology, 1979
A patient with extensive systemic mastocytosis and the mastocytosis syndrome was studied by light and electron microscopy. Mast cell proliferation was found in the bone marrow, the liver, spleen and lymph node. In addition, the patient had telangiectasia macularis eruptiva perstans and elevated histamine levels.
G D, Monheit, T, Murad, M, Conrad
openaire   +2 more sources

Home - About - Disclaimer - Privacy